The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Industry s Direct’s proprietary databases, Firms ’s corporate website, SEC filings, investor presentations and featured press releases, both from industry player and market -specific third party sources, put together by Global Industry s Direct’s team.

Scope of the Research

- University of Sao Paulo - Brief industry player overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of University of Sao Paulo human therapeutic division.
- Detailed Analysis of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of University of Sao Paulo with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the University of Sao Paulo’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Why Should You Get This Report?

- Evaluate University of Sao Paulo’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of University of Sao Paulo in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the University of Sao Paulo’s Research and Development portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with University of Sao Paulo.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of University of Sao Paulo and identify potential opportunities in those areas.

Table Of Contents

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
University of Sao Paulo Snapshot 5
University of Sao Paulo Overview 5
Key Information 5
Key Facts 5
University of Sao Paulo - Research and Development Overview 6
Key Therapeutic Areas 6
University of Sao Paulo - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Pipeline Products - Combination Treatment Modalities 11
University of Sao Paulo - Pipeline Products Glance 12
University of Sao Paulo - Late Stage Pipeline 12
Phase III Products/Combination Treatment Modalities 12
University of Sao Paulo Clinical Stage Pipeline Products 13
Phase II Products/Combination Treatment Modalities 13
Phase I Products/Combination Treatment Modalities 14
University of Sao Paulo - Drug Profiles 15
Bevacizumab + Laser Photocoagulation 15
Product Description 15
Mechanism of Action 15
RandD Progress 15
GnRH agonist 16
Product Description 16
Mechanism of Action 16
RandD Progress 16
Sertraline 17
Product Description 17
Mechanism of Action 17
RandD Progress 17
Triamcinolone + Laser Photocoagulation 18
Product Description 18
Mechanism of Action 18
RandD Progress 18
Valproic Acid 19
Product Description 19
Mechanism of Action 19
RandD Progress 19
Acetazolamide 20
Product Description 20
Mechanism of Action 20
RandD Progress 20
Brimonidine tartarate 21
Product Description 21
Mechanism of Action 21
RandD Progress 21
Lithium Carbonate 22
Product Description 22
Mechanism of Action 22
RandD Progress 22
Magnesium sulfate 23
Product Description 23
Mechanism of Action 23
RandD Progress 23
Ozone 24
Product Description 24
Mechanism of Action 24
RandD Progress 24
Propranolol 26
Product Description 26
Mechanism of Action 26
RandD Progress 26
Propranolol + Prednisone 27
Product Description 27
Mechanism of Action 27
RandD Progress 27
Autologous Bone March row-Derived Stem Cells 28
Product Description 28
Mechanism of Action 28
RandD Progress 28
Ozone 29
Product Description 29
Mechanism of Action 29
RandD Progress 29
University of Sao Paulo - Pipeline Analysis 31
University of Sao Paulo - Pipeline Products by Therapeutic Class 31
University of Sao Paulo Pipeline Products By Target 33
University of Sao Paulo - Pipeline Products by Route of Administration 35
University of Sao Paulo - Pipeline Products by Molecule Type 36
University of Sao Paulo - Locations And Subsidiaries 37
Head Office 37
Appendix 38
Methodology 38
Coverage 38
Secondary Research 38
Primary Research 38
Expert Panel Validation 39
Contact Us 39
Disclaimer 39List of Tables
University of Sao Paulo - Pipeline by Therapy Area and Indication, 2010 8
University of Sao Paulo - Pipeline by Stage of Development, 2010 9
University of Sao Paulo - Monotherapy Products in Pipeline, 2010 10
University of Sao Paulo - Combination Treatment Modalities in Pipeline, 2010 11
University of Sao Paulo - Phase III, 2010 12
University of Sao Paulo - Phase II, 2010 13
University of Sao Paulo - Phase I, 2010 14
University of Sao Paulo - Pipeline By Therapeutic Class, 2010 31
University of Sao Paulo - Pipeline By Target, 2010 34
University of Sao Paulo - Pipeline By Route of Administration, 2010 35
University of Sao Paulo - Pipeline By Molecule Type, 2010 36

List of Figures
University of Sao Paulo - Pipeline by Therapy Area and Indication, 2010 7
University of Sao Paulo - Pipeline by Stage of Development, 2010 9
University of Sao Paulo - Monotherapy Products in Pipeline, 2010 10
University of Sao Paulo - Combination Treatment Modalities in Pipeline, 2010 11
University of Sao Paulo - Pipeline By Therapeutic Class, 2010 31
University of Sao Paulo - Pipeline By Target, 2010 33
University of Sao Paulo - Pipeline By Route of Administration, 2010 35
University of Sao Paulo - Pipeline By Molecule Type, 2010 36

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Shadi

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers

Diagnostics and Therapeutics for HIV: Global Markets

Diagnostics and Therapeutics for HIV: Global Markets

  • $ 6 650
  • Industry report
  • April 2014
  • by BCC Research

STUDY GOALS AND OBJECTIVES The aim of this report is to provide detailed market, technology and industry analyses to help readers quantify and qualify the market for products used in the treatment, testing ...

JAK and PI3K Signaling Pathway Markets

JAK and PI3K Signaling Pathway Markets

  • $ 6 650
  • Industry report
  • April 2014
  • by BCC Research

REPORT HIGHLIGHTS The global market for signal transduction therapies/inhibitors (JAK and PI3K) reached $173.5 million in 2012. This market is expected to grow to $464.5 million in 2013 and $2.2 billion ...

Therapeutics for Women%s Health: Technologies and Global Markets

Therapeutics for Women%s Health: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • May 2014
  • by BCC Research

Use this report to: - Learn about the main women's health disorders and relevant disease prevalence population. - Identify the impact of demographic, economic, and other factors that will drive future ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.